Epigenetic Targets of Arsenic: Emphasis on Epigenetic Modifications During Carcinogenesis

被引:24
|
作者
Roy, Ram Vinod
Son, Young-Ok
Pratheeshkumar, Poyil
Wang, Lei
Hitron, John Andrew
Divya, Sasidharan Padmaja
Rakesh, D.
Kim, Donghern
Yin, Yuanqin
Zhang, Zhuo
Shi, Xianglin [1 ]
机构
[1] Univ Kentucky, Ctr Res Environm Dis, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
epigenetics; DNA methylation; histone modification; chromatin; miRNAs; transgenerational; intergeneration; arsenic; carcinogenesis; epigenome; prenatal exposure; INDUCED MALIGNANT-TRANSFORMATION; ENDOCRINE DISRUPTOR VINCLOZOLIN; DE-NOVO METHYLATION; DNA METHYLATION; DRINKING-WATER; GENE-EXPRESSION; TRANSGENERATIONAL ACTIONS; HISTONE MODIFICATIONS; TRANSCRIPTION FACTOR; DOWN-REGULATION;
D O I
10.1615/JEnvironPatholToxicolOncol.2014012066
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
DNA methylation and histone modification promote opening and closure of chromatin structure, which affects gene expression without altering the DNA sequence. Epigenetic markers regulate the dynamic nature of chromatin structure at different levels: DNA, histone, noncoding RNAs, as well as the higher-order chromatin structure. Accumulating evidence strongly suggests that arsenic-induced carcinogenesis involves frequent changes in the epigenetic marker. However, progress in identifying arsenic-induced epigenetic changes has already been made using genome-wide approaches; the biological significance of these epigenetic changes remains unknown. Moreover, arsenic-induced changes in the chromatin state alter gene expression through the epigenetic mechanism. The current review provides a summary of recent literature regarding epigenetic changes caused by arsenic in carcinogenesis. We highlight the transgenerational studies needed to explicate the biological significance and toxicity of arsenic over a broad spectrum.
引用
收藏
页码:63 / 84
页数:22
相关论文
共 50 条
  • [1] Epigenetic Modifications as Therapeutic Targets
    Zheng, Yi-Chao
    Feng, Si-Qi
    CURRENT DRUG TARGETS, 2020, 21 (11) : 1046 - 1046
  • [2] Epigenetic modifications as therapeutic targets
    Kelly, Theresa K.
    De Carvalho, Daniel D.
    Jones, Peter A.
    NATURE BIOTECHNOLOGY, 2010, 28 (10) : 1069 - 1078
  • [3] Epigenetic modifications as therapeutic targets
    Theresa K Kelly
    Daniel D De Carvalho
    Peter A Jones
    Nature Biotechnology, 2010, 28 : 1069 - 1078
  • [4] Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis
    Gao, Yue
    Zhang, Siyu
    Zhang, Xianhong
    Du, Yitian
    Ni, Ting
    Hao, Shuailin
    ISCIENCE, 2024, 27 (12)
  • [5] Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis
    Islam, Ranakul
    Zhao, Lei
    Wang, Yifang
    Lu-Yao, Grace
    Liu, Ling-Zhi
    CANCERS, 2022, 14 (18)
  • [6] Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis
    Hyung Sik Kim
    Sam Kacew
    Byung Mu Lee
    Archives of Toxicology, 2016, 90 : 2389 - 2404
  • [7] Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis
    Kim, Hyung Sik
    Kacew, Sam
    Lee, Byung Mu
    ARCHIVES OF TOXICOLOGY, 2016, 90 (10) : 2389 - 2404
  • [8] Effects of arsenic toxicity beyond epigenetic modifications
    Geir Bjørklund
    Jan Aaseth
    Salvatore Chirumbolo
    Mauricio A. Urbina
    Riaz Uddin
    Environmental Geochemistry and Health, 2018, 40 : 955 - 965
  • [9] Effects of arsenic toxicity beyond epigenetic modifications
    Bjorklund, Geir
    Aaseth, Jan
    Chirumbolo, Salvatore
    Urbina, Mauricio A.
    Uddin, Riaz
    ENVIRONMENTAL GEOCHEMISTRY AND HEALTH, 2018, 40 (03) : 955 - 965
  • [10] An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis
    Ren, Xuefeng
    McHale, Cliona M.
    Skibola, Christine F.
    Smith, Allan H.
    Smith, Martyn T.
    Zhang, Luoping
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (01) : 11 - 19